Latest Asx News

RPMGlobal has secured a crucial Foreign Investment Review Board approval for its proposed acquisition by Caterpillar, marking a significant step forward in the takeover process.

LTR Pharma has initiated dosing in its Phase II clinical trial for SPONTAN, a rapid-acting intranasal spray targeting erectile dysfunction, marking a key step toward FDA approval and commercial expansion.

Ionic Rare Earths has secured a listing on the U.S. OTCQB Venture Market, enhancing access for American investors to its rare earth and magnet recycling ventures. This move aligns the company with North American critical minerals priorities and broadens its global investor base.

1414 Degrees updates on the administration of its joint venture partner Vast Solar Aurora, exploring acquisition options while progressing key renewable projects. The company also advances its October 2025 placement with shareholder-approved options now moving towards ASX quotation.

Cannindah Resources has pinpointed a promising high-grade copper-gold target in the under-drilled southern section of its Cannindah Breccia resource, with a new drilling campaign set to begin shortly.

Peel Mining has initiated a 9-hole drilling program at its Southern Nights Complex in NSW, targeting expansion of its significant silver-rich polymetallic resource. The campaign aims to unlock new high-grade zones and enhance geological insights within the South Cobar Project.

Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.

Gateway Mining has announced a significant new gold discovery at its Haflinger target within the Yandal Gold Project, with drilling intersecting 52 metres at 1.4g/t gold, including a higher-grade 12-metre section at 3.1g/t. This extends a mineralised trend over 500 metres, highlighting a structurally complex and promising geological setting.

Entropy Neurodynamics reports encouraging early clinical results from the first patient treated with TRP-8803, an IV-infused psilocin therapy for Binge Eating Disorder, showing improvements across multiple symptom areas.

West Wits Mining has upsized its institutional placement to A$33.74 million, anchored by a $10 million strategic investment from Tribeca Investment Partners, fully funding the Qala Shallows project ahead of first gold pour in March 2026.

Pantoro Gold delivered a solid December quarter with strong gold production, robust EBITDA, and promising exploration results at its Norseman Gold Project.

Hazer Group advances its methane pyrolysis technology commercialization with a landmark alliance deal, extended partnerships, and a strengthened cash position, positioning itself at the forefront of low-carbon hydrogen and steelmaking solutions.